PhRMA CEO Tauzin Takes Over Jan. 3: PR Focus Begins At The Top
This article was originally published in The Tan Sheet
PhRMA's new management team under CEO Billy Tauzin will place a high priority on communications and partnerships with other stakeholders in healthcare policy debates
You may also be interested in...
Rep. Joe Barton (R-Tex.) could be named to fill chairman seat at the House Energy & Commerce Committee as early as week of Feb. 9, staffers say. Barton is lead candidate to replace Billy Tauzin (R-La.), who steps down as chair effective Feb. 16. Tauzin is rumored to be the top choice to head the Pharmaceutical Research & Manufacturers of America. Under Tauzin, committee held hearings on dietary supplement safety, with a focus on ephedra, in 2003. As chair of the Commerce/Oversight & Investigations Subcommittee in mid to late 1990s, Barton examined a number of health-related issues...
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
Combe sells most of its OTC brands